Evidence map›Paper›PMID 42665418›Full record

ArticleIn vivo (Athens, Greece)

Colitis Ameliorates Murine Autoimmune Cholangitis Through Polarization of M2 Macrophages and Inhibition of CD8

Miao He, Haoqing Liu, Miaomiao Zhang, Binghui Liu, Qiqi Cai, Zaixing Yang, Jie Li

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miao He *Department of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Haoqing Liu *Department of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Miaomiao ZhangDepartment of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Binghui LiuDepartment of Pathology, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Qiqi CaiDepartment of Emergency Intensive Care Unit, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Zaixing YangDepartment of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China; yangzaixingdiyi@wmu.edu.cn.
Jie LiDepartment of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China; lijie_tfph26@wmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimPrimary biliary cholangitis (PBC) is a form of chronic autoimmune cholangitis of enigmatic etiology and pathogenesis. While numerous studies indicate an association between inflammatory bowel disease (IBD) and PBC, the bidirectional impact on disease progression remains unclear. This study investigated the role of colitis in PBC progression using a mouse model of IBD-PBC. MATERIALS AND

methodsAcute experimental colitis was induced using dextran sodium sulfate in transgenic mice with PBC to establish an IBD-PBC model. Colon and liver tissues were analyzed by histopathology, flow cytometry, and immunostaining. Inflammatory mediators and metabolomic changes were further evaluated using quantitative real-time polymerase chain reaction and untargeted metabolomics.

resultsWe found that acute experimental colitis exacerbated colonic injury in PBC mice but concurrently attenuated hepatic inflammation. This hepatic effect was characterized by reduced liver-infiltrating lymphocytes (particularly CD8

conclusionCollectively, these findings suggest that experimental acute colitis may promote hepatic M2 macrophage polarization in mice with PBC, potentially through modulation of specific metabolites, thereby inhibiting CD8

Indexed as

Autoimmune DiseasesCD8-Positive T-LymphocytesCholangitisColitisMacrophagesAnimalsBiomarkersCell PolarityCytokinesDextran SulfateDisease Models, AnimalInflammation MediatorsLiverLiver Cirrhosis, BiliaryMacrophage ActivationMetabolomicsBiomarkersCytokinesDextran SulfateInflammation MediatorsCD8+ T-cell inhibitionColitisdextran sodium sulfateM2 macrophage polarizationprimary biliary cholangitisuntargeted metabolomics

Identifiers

PMID42665418
PMCPMC13531166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.